Literature DB >> 1945747

Bile acids and their amidates inhibit 11 beta-hydroxysteroid dehydrogenase obtained from rat kidney.

F H Perschel1, H Bühler, K Hierholzer.   

Abstract

Recently it has been demonstrated that interaction of corticosteroids with extraadrenal target cells can effectively be modulated by metabolic transformation of the steroid hormone. As far as 11-hydroxylated glucocorticoids are concerned 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD) is the most important enzyme charged with target cell metabolism. Inhibition of 11 beta-HSD function either by genetically transmitted deficiency or by exogenous enzyme inhibitors causes severe pathophysiological derangements, which result in a syndrome of "apparent mineralocorticoid excess". In the present paper we have tested whether or not endogenous inhibitors of this enzyme system might exist. The effects of the main naturally occurring mono-, di-, and trihydroxylated bile acids in man on 11 beta-HSD have been studied in in vitro experiments. Using rat renal microsomes it could be demonstrated that unconjugated bile acids of all three classes as well as the corresponding glycine and taurine amidates effectively inhibit oxidative as well as reductive activity of 11 beta-HSD, with lithocholic acid and chenodeoxycholic acid being the most potent compounds. It is concluded that bile acids are potent endogenous inhibitors of 11 beta-HSD and, therefore, could participate in abnormalities of cortisol metabolism observed in liver cirrhosis and extrahepatic biliary obstruction and, possibly, after ingestion of bile acids.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1945747     DOI: 10.1007/bf00370568

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  21 in total

1.  Inhibition of 11 beta-hydroxysteroid dehydrogenase and its effect on epithelial sodium transport.

Authors:  K Hierholzer; H Siebe; M Fromm
Journal:  Kidney Int       Date:  1990-10       Impact factor: 10.612

2.  Effect of bile acids and some biliary excreted drugs on the metabolism of cortisol.

Authors:  H Gerdes; H Riemenschneider; K P Littmann
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1973

3.  Cortisol metabolism in total extrahepatic biliary obstruction.

Authors:  B Zumoff; H L Bradlow; T F Gallagher; L Hellman
Journal:  J Clin Endocrinol Metab       Date:  1971-01       Impact factor: 5.958

4.  Corticosteroid metabolism in isolated rat kidney in vitro. I. Formation of lipid soluble metabolites from corticosterone (B) in renal tissue from male rats.

Authors:  K Hierholzer; M Schöneshöfer; H Siebe; D Tsiakiras; P Weskamp
Journal:  Pflugers Arch       Date:  1984-04       Impact factor: 3.657

5.  Cortisol metabolism in cirrhosis.

Authors:  B Zumoff; H L Bradlow; T F Gallagher; L Hellman
Journal:  J Clin Invest       Date:  1967-11       Impact factor: 14.808

6.  Corticosteroid metabolism in rat kidney in vitro. IV. Subcellular, sites of 11 beta-hydroxysteroid dehydrogenase activity.

Authors:  N Kobayashi; W Schulz; K Hierholzer
Journal:  Pflugers Arch       Date:  1987-01       Impact factor: 3.657

7.  Naturally occurring conjugated bile acids, measured by high-performance liquid chromatography, in human, dog, and rabbit bile.

Authors:  H J Wildgrube; H Stockhausen; J Petri; U Füssel; H Lauer
Journal:  J Chromatogr       Date:  1986-02-26

8.  Direct measurement of hepatic extraction of bile acids in subjects with and without liver disease.

Authors:  I T Gilmore; R P Thompson
Journal:  Clin Sci (Lond)       Date:  1981-01       Impact factor: 6.124

9.  Aldosterone metabolism in rat renal tissue in vitro. Formation of lipid soluble metabolites.

Authors:  D l'Allemand; H Siebe; D Tsiakiras; G A Hoyer; P Vecsei; K Hierholzer
Journal:  Pflugers Arch       Date:  1988-05       Impact factor: 3.657

10.  Serum bile acids in liver disease.

Authors:  G Neale; B Lewis; V Weaver; D Panveliwalla
Journal:  Gut       Date:  1971-02       Impact factor: 23.059

View more
  4 in total

1.  Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis.

Authors:  C Quattropani; B Vogt; A Odermatt; B Dick; B M Frey; F J Frey
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

Review 2.  Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease.

Authors:  Patrick W F Hadoke; Javaid Iqbal; Brian R Walker
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

3.  Influence of human serum albumin on the bile acid-mediated inhibition of liver microsomal type 1 11β-hydroxysteroid dehydrogenase.

Authors:  Yorio Maeda; Mayumi Funagayama; Akio Shinohara; Chihiro Koshimoto; Hidemi Furusawa; Hiroshi Nakahara; Yukiko Yamaguchi; Tomokazu Saitoh; Takashi Yamamoto; Kansei Komaki
Journal:  J Physiol Biochem       Date:  2014-08-10       Impact factor: 4.158

4.  11β-hydroxysteroid dehydrogenase-1 deficiency alters the gut microbiome response to Western diet.

Authors:  Jethro S Johnson; Monica N Opiyo; Marian Thomson; Karim Gharbi; Jonathan R Seckl; Andreas Heger; Karen E Chapman
Journal:  J Endocrinol       Date:  2016-11-24       Impact factor: 4.286

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.